Physician profile
Priscilla Gooslin
NPI 1568414902
$1,164.54
in general payments reported to CMS, 2019-2025
12 companies · $58.94 in 2025
The $58.94 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $127 · 2023: $397 · 2024: $354 · 2025: $58.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $434.72 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $178.66 | 2021-2022 | |
| Philips North America LLC | $158.18 | 2023-2024 | (5044) Mcot, (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $96.33 | 2023-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $86.68 | 2021-2024 | Brilinta |
| Amarin Pharma, INC. | $60.44 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $42.55 | 2023-2025 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.11 | 2023 | Lifevest |
| Abbott Laboratories | $28.36 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lexicon Pharmaceuticals, INC. | $17.86 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $15.90 | 2025 | Assure Wcd |
| Pfizer INC. | $14.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Gooslin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.